What does “Nadac” mean, and where does the price history come from?
“NADAC” usually refers to the National Average Drug Acquisition Cost. Price-history charts labeled “NADAC” are typically built from pharmacy acquisition cost reporting, so they track what pharmacies paid for the drug over time rather than what patients paid at the pharmacy counter.
How can I find Nadac price history specifically for Neurontin 300 mg capsules?
The fastest way is to look up Neurontin 300 mg (gabapentin) in a NADAC price-history tool and then filter to:
- Product strength: 300 mg
- Dosage form: capsule
- Package/NDC: the specific marketed package matters because different package sizes/NDCs can show different lines
If you tell me the exact NDC (or the package size, e.g., 90-count bottle, 30-count bottle), I can help pinpoint the correct series to use for the price history.
Why might the Nadac history move up or down?
NADAC can change for reasons that don’t always line up with “market demand,” including:
- Manufacturer or labeler changes for a given NDC
- Package size swaps
- Periodic reporting updates
- Shifts in acquisition costs across reporting pharmacies
Is Neurontin 300 mg capsule price history different from generic gabapentin?
It can be. Even when the active ingredient is the same (gabapentin), branded Neurontin versus specific generic manufacturers can have different NDCs and different NADAC series. Price-history charts often show multiple lines unless you filter tightly.
If you mean branded Neurontin vs generic gabapentin, which one?
To avoid mixing different products, confirm one of these:
- Branded Neurontin 300 mg capsules, or
- Generic gabapentin 300 mg capsules (and if generic, the manufacturer or NDC)
Next step: share the NDC or package details
Reply with either:
- The NDC number for your exact Neurontin 300 mg capsule package, or
- Package size (count) and whether it’s Neurontin branded or generic
Then I can help you interpret the NADAC price history and identify key time periods (high/low points and the approximate change).
Sources: None provided.